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doi:10.1016/j.jtcvs.2005.02.047Objectives: Little attention has been paid to the effect of the systemic inflammatory
response syndrome on intestinal dysfunction in the postoperative period. Several
proinflammatory cytokines have been reported to increase the permeability of
intestinal mucosa in vitro. We investigated the effect of dexamethasone on gut
permeability in pediatric patients undergoing cardiac surgery by using the dual sugar
permeability test and absorption of 2 other saccharides.
Methods: Thirty-four patients scheduled for cardiac surgery with cardiopulmonary
bypass were prospectively randomized to either act as control subjects or to receive
dexamethasone (1 mg · kg1) during induction of anesthesia. Intestinal permeability
was measured with 3-O-methyl-D-glucose, D-xylose, L-rhamnose, and lactulose
administered orally after induction of anesthesia and 12 and 24 hours later.
Results: Lactulose/rhamnose ratios were increased from the outset in both groups
(mean 0.57 [95% confidence interval, 0.24-0.91] for the control group and 0.76
[95% confidence interval, 0.35-1.17] for patients receiving dexamethasone). Al-
though the ratios decreased 12 hours (0.29 [95% confidence interval, 0.17-0.42])
and 24 hours later (0.17 [95% confidence interval, 0.08-0.15]) in the dexamethasone
group, in the control group there was a rise at 12 hours (0.77 [95% confidence
interval, 0-1.64]), with a slight reduction 24 hours later (0.46 [95% confidence
interval, 0.06-0.85]).
Conclusions: Infants and children undergoing cardiac surgery with cardiopulmonary
bypass show a significant reduction in gut permeability when dexamethasone is used
during induction of anesthesia. Dexamethasone does not affect the intestinal barrier
at the functional level, as assessed on the basis of 3-O-methyl-D-glucose and
D-xylose absorption.
Cardiopulmonary bypass (CPB) can trigger a systemic inflammatory responsesyndrome. This might result postoperatively in fever, fluid retention, andpulmonary, renal, cardiac, and cerebral dysfunction.1 Little attention has
been paid to the effect of CPB and the associated systemic inflammatory response
on intestinal dysfunction in the postoperative period.
The postoperative release of inflammatory mediators after pediatric cardiac
surgery has been reviewed extensively elsewhere.2 Several proinflammatory cyto-
kines have been reported to increase the permeability of intestinal mucosa in vitro.3
Anti-inflammatory cytokines, on the other hand, ameliorated induced gut epithelial
hyperpermeability in vitro.4 The mechanisms involved in this phenomenon are not
totally clear.
Intestinal permeability can be evaluated noninvasively by measuring the urinary
excretion of orally administered, water-soluble, nondegradable test molecules.5,6
This barrier function test is based on the comparison of intestinal permeation of
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ferent routes of intestinal permeation: the larger molecules
are assumed to permeate paracellularly, and the smaller
molecules are assumed to permeate transcellularly. Preab-
sorption factors, such as gastric emptying, dilution by
means of secretion, and intestinal transit time, and postab-
sorption factors, such as systemic distribution and renal
clearance, are assumed to affect both molecules equally.
Four saccharides, 3-O-methyl-D-glucose (molecular weight,
194 d), D-xylose (molecular weight, 150 d), L-rhamnose
(molecular weight, 164 d), and lactulose (molecular weight,
342 d) are used to assess active carrier–mediated, passive
carrier–mediated, transcellular, and paracellular transport,
respectively, in the small intestine. Intestinal permeability is
considered to be normal if the lactulose (percentage recov-
ery)/rhamnose (percentage recovery; L/R) ratio is less than
0.05.5 Intestinal absorptive capacity for saccharides is con-
sidered to be normal when the minimum recoveries of
D-xylose (passive carrier-mediated transport) and 3-O-methyl-
D-glucose (active carrier–mediated transport) are around
10% and 30%, respectively.7 A previous study has shown
that preoperative L/R ratios in patients with congenital heart
defects are on average up to 8 times higher than in healthy
neonates.8
The possible clinical applications of the dual sugar per-
meability test (DSPT) have not been explored in this group
of patients. Gastrointestinal complications in the postoper-
ative period are rare but are accompanied by devastating
consequences, such as necrotizing enterocolitis in patients
with the hypoplastic left heart syndrome.9 The DSPT might
be used as a surrogate marker to test the effect of drugs or
novel therapies on the splanchnic circulation.
The use of steroids in cardiac surgery remains contro-
versial.10 There is evidence in the literature that steroids,
administered before the start of CPB, reduce the release of
proinflammatory mediators associated with both adult and
pediatric cardiac surgery.11,12 However, the benefits of ste-
roids on clinical outcome are not totally proved.13
The aim of our study was to observe the effect of a single
dose of dexamethasone before CPB starts on the changes in
gut permeability in pediatric cardiac surgery with the
DSPT.
Patients and Methods
After obtaining approval from the local ethics committee and
informed consent from the parents or legal guardians, we enrolled
34 patients in this prospective, randomized, single-blind interven-
tional study. Patients were allocated to receive either dexametha-
sone (1 mg · kg1 during induction of anesthesia) or act as control
subjects. The use of placebo is not allowed by our local ethics
committee. Patients received a premedication consisting of oral
atropine (0.02 mg · kg1) and midazolam (0.5 mg · kg1) 30 min-
utes before induction of anesthesia. Anesthesia was induced with
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sisted of a combined continuous infusion of midazolam (0.2
mg · kg1 · h1) and sufentanil (2 g · kg1 · h1). The lungs of
the patients were mechanically ventilated with a mixture of oxygen
and air. Mechanical ventilation was maintained until CPB com-
menced. After heparin administration (3 mg · kg1) and aorta
cannulation, CPB was instituted with a Dideco hollow-fiber oxy-
genator (Dideco SpA, Mirandola, Italy) with a blood flow of
between 200 and 300 mL · kg1 · min1. The prime volume, be-
tween 325 and 750 mL according to the patient’s weight, contained
lactate-free Ringer solution, albumin, mannitol, blood, and hepa-
rin. No steroids were added to the prime. Patients underwent
modified ultrafiltration at the end of the surgical procedure. The
effect of heparin was reversed with protamine sulfate in a ratio of
1 mg of protamine for 1 mg of heparin.
After induction of anesthesia, 2 mL · kg1 of the sugar solution
was administered through a nasogastric tube. Urine was subse-
quently completely collected through a urinary catheter for 3
hours, the total volume was recorded, and samples were stored at
20°C until analysis. This process was repeated 12 and 24 hours
after induction of anesthesia. The sugar solution, prepared by the
hospital pharmacy, contained 3-O-methyl-D-glucose (2 g · L1),
D-xylose (5 g · L1), L-rhamnose (10 g · L1), and lactulose (50
g · L1). The osmolarity of the solution is approximately 240
mOsm · L1.
Sugar concentrations in urine were determined by gas chroma-
tography, according to a slight modification14 of the procedure
described by Jansen and colleagues.15 In brief, to an aliquot of
urine corresponding to 0.5 mol of creatinine, 30 g of ribitol and
10 g of trehalose (Sigma-Aldrich, St Louis, Mo) were added as
internal standards (ribitol for the determination of 3-O-methyl-D-
glucose, D-xylose, and L-rhamnose and trehalose for lactulose).
The sample was dried, derivatized with 300 L of Tri-Sil TBT
(Pierce, Rockford, Ill) at 100°C, and partly hydrolyzed with water.
Subsequently, the intact sugar trimethylsilyl derivatives were ex-
tracted with hexane, and after concentrating, gas chromatographic
analysis was performed on a 30-m capillary fused silica HP-1
column (Agilent, Palo Alto, Calif) by split injection. Quantification
was performed after the construction of standard addition calibra-
tion curves.
The type of vasoactive drugs and their amounts were recorded
after admission to the intensive care unit and 24 hours later. To
quantify inotropic support, we calculated inotrope scores as the
sum of all inotrope doses correcting for potency (dopamine and
dobutamine  1, milrinone  15, epinephrine  100).16 Fluid
intake (including crystalloids, colloids, and blood products), out-
put (urine, blood, and serous fluid loss), and balance were recorded
over a 36-hour period after admission to the intensive care unit.
Urea and creatinine concentrations were measured preoperatively,
immediately after admission to the intensive care unit, and 24
hours later.
Data were analyzed with the statistical package SPSS v10
(SPSS, Inc, Chicago, Ill). Data are presented as means with 95%
confidence intervals (CIs). Patient characteristics (age, weight,
surgical times, and ventilator hours), fluid balance, and inotropic
scores were analyzed with unpaired t tests. Because L/R ratios and
percentage recovery of the other 2 sugars were not normally
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transformation. We used repeated-measures analysis of variance to
compare the 2 time points (T12 and T24) using dexamethasone as
the between-subject factor. On the basis of a previous study6 that
found a mean (standard deviation [SD]) L/R ratio of 0.047 (0.018),
a prospective analysis showed that we needed a sample size of 34
to detect a difference in the L/R ratio of 0.02 with an  value of .05
and a power of 80%.
Results
Table 1 shows patient characteristics. Ventilator hours are
similar in both groups. Inotropic scores are not significantly
different either between the 2 groups at the 2 time periods or
within each group. The total fluid balance over the 36-hour
study period was not significantly different between the 2
groups. The types of operations performed in each group are
shown in Table 2. Table 3 shows the L/R ratios and per-
centage recovery of the 4 sugars throughout the study period
together with the P value for each parameter. Differences in
L/R ratios between the 2 groups were statistically signifi-
cant. Differences in percentage recovery for rhamnose and
3-O-methyl-D-glucose were also significant between the 2
groups. There were no significant differences in the percent-
age recovery of lactulose and D-xylose between the 2
groups.
Urea and creatinine concentrations remained within
the normal clinical range throughout the study period. In
the control group, urea concentrations (normal range,
0.7-6.7 mmol · L1) were 4.8 mmol · L1 (95% CI, 4-5.5
mmol · L1) preoperatively, 4.1 mmol · L1 (95% CI, 3.4-
4.8 mmol · L1) immediately after the operation, and 5.9
mmol · L1 (95% CI, 4.9-6.8 mmol · L1) 24 hours later. In
the dexamethasone group, urea concentrations were 4
mmol · L1 (95% CI, 3.4-4.6 mmol · L1) preoperatively, 4
mmol · L1 (95% CI, 3.3-4.7 mmol · L1) immediately af-
ter the operation, and 5.5 mmol · L1 (95% CI, 4.7-6.3
mmol · L1) 24 hours later. Creatinine concentrations (nor-
mal value, 70 mol · L1) were, in the control group,
TABLE 1. Patient characteristics
No dexamethasone Dexamethasone P value
No. of patients 17 17
Age (mo) 12 (5-19) 4 (2-6) .02
Sex (M/F) 6/11 7/10 .46
Weight (kg) 7 (5-9) 5 (4-6) .01
Surgical time (min) 181 (152-211) 190 (145-234) .65
Bypass time (min) 118 (100-135) 118 (87-149) .66
Aortic clamp time (min) 64 (46-83) 78 (52-104) .58
Ventilator hours 52 (33-71) 81 (27-135) .79
Inoscore 4 (2-6) 7 (2-11) .83
Inoscore, 24 h 6 (3-10) 7 (1-13) .58
Balance (mL · kg1) 29 (3-55) 33 (12-54) .89
Values are expressed as means (95% confidence intervals).
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after the operation, and 52 mol · L1 (95% CI, 41-63
mol · L1) 24 hours later. In the dexamethasone group,
creatinine concentrations were 31 mol · L1 (95% CI,
25-38 mol · L1) preoperatively, 31 mol · L1 (95% CI,
26-37 mol · L1) immediately after the operation, and 34
mol · L1 (95% CI, 28-39 mol · L1) 24 hours later. None
of the patients had acute renal failure during the study period.
Figures 1 to 5 are representations of the changes in L/R
ratios and percentage recovery for lactulose, rhamnose,
D-xylose, and 3-O-methyl-D-glucose in both groups.
Discussion
We have shown in this study that dexamethasone adminis-
tered before the commencement of CPB reduces postoper-
ative gut permeability, as assessed by the DSPT.
There was an age and weight difference between the 2
groups. This could be seen as a limiting factor in the
interpretation of the results. Univariate analysis showed that
neither variable influenced either L/R ratios or percentage
recovery of the other 2 sugars. The DSPT has been used to
assess intestinal function in healthy neonates, in whom the
L/R ratios were around 0.05.5 Similar values were found in
healthy children (range, 0.023-0.074; mean [SD], 0.047
[0.018]).6
Gut permeability has been investigated in adult patients
undergoing coronary artery bypass surgery.17 L/R ratios
increased immediately after surgical intervention, returning
to normal values approximately 48 hours after the surgical
procedure. The DSPT has also been used to test the bene-
ficial effects of dopexamine over dopamine in the splanch-
nic circulation during adult coronary bypass surgery.18
The accuracy of the DSPT relies on the complete collec-
TABLE 2. Surgical procedures
No dexamethasone Dexamethasone
VSD 7 6
ToF 1 1
TAPVC 2 2
Arterial switch 0 4
Rastelli 0 1
PA, MAPCA 0 1
AVSD 2 0
AVA 1 0
BCPA 2 1
MVA 2 1
Total 17 17
VSD, Ventricular septal defect; ToF, tetralogy of Fallot; TAPVC, total anom-
alous pulmonary venous connection; PA, pulmonary atresia; MAPCA, ma-
jor aortopulmonary collateral arteries; AVSD, atrioventricular septal defect;
AVA, aortic valve annuloplasty; BCPA, bidirectional cavopulmonary anas-
tomosis; MVA, mitral valve annuloplasty.
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limiting factor on the applicability of the test in noncoop-
erative patients without a urinary catheter. A high percent-
age of patients are discharged to the ward the day after
surgical intervention, with consequent removal of urinary
catheters. For this reason, we performed the test during the
first 24 hours after the operation.
There has been criticism concerning the interpretation and
significance of the DSPT in the literature.19,20 In an animal
model it was shown that fluid loading increased the L/R ratios
independent of changes in intestinal permeability. In an 8-hour
Figure 1. Changes in L/R ratios in both groups. Values are ex-
pressed as means (95% CI). , T0; , T12; ‘, T24. *Statistical
TABLE 3. Lactulose/rhamnose ratios and percentage recove
without and with dexamethasone
T0
L/R ratios
No dexamethasone 0.57 (0.24-0.91)
Dexamethasone 0.76 (0.35-1.17)
Lactulose
No dexamethasone 0.07 (0.02-0.12)
Dexamethasone 0.08 (0.02-0.14)
Rhamnose
No dexamethasone 0.16 (0.02-0.30)
Dexamethasone 0.16 (0.02-0.31)
D-xylose
No dexamethasone 0.29 (0.14-0.45)
Dexamethasone 0.34 (0.08-0.60)
3OMG
No dexamethasone 0.38 (0.12-0.64)
Dexamethasone 0.33 (0.09-0.57)
Values are expressed as means (95% confidence intervals). L/R, Lactulose/
groups.
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268 The Journal of Thoracic and Cardiovascular Surgery ● Auguperiod rats received a fluid bolus equivalent to twice the daily
fluid oral intake. Put into perspective, this means an infant of
10 kg would receive approximately 2 L of fluid intravenously
in an 8-hour period. We carefully documented the fluid balance
during the study period. On average, patients received less than
the daily maintenance fluid expected for their age.
The DSPT relies on the assumption that when lactulose
and rhamnose are combined in the test solution at a fixed
concentration ratio, the effect of preabsorption factors (gas-
tric emptying, dilution by secretions, and intestinal transit
Figure 2. Changes of lactulose percentage recovery in both
groups. Values are expressed as means (95% CI). , T0; , T12;
r lactulose, rhamnose, D-xylose, and 3-O-methyl-D-glucose
T12 T24 P value
(0-1.64) 0.46 (0.06-0.85)
(0.17-0.42) 0.17 (0.08-0.15) .019
(0.22-0.4) 0.87 (0.51-1.23)
(0.34-0.89) 1.07 (0.11-2.04) .056
(0.68-2.2) 4.59 (2.23-6.94)
(1.36-4.69) 6.18 (3.35-9) .047
(0.42-2.75) 5.69 (2.41-8.96)
(1.83-4.09) 5.47 (2.59-8.34) .056
(1.21-5.54) 14.42 (6.19-22.6)
(3.32-11.33) 13 (6.59-19.42) .041
nose ratio; 3OMG, 3-O-methyl-D-glucose. *Statistically significant between
CT
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0.77
0.29
0.31
0.62
1.44
3.02
1.58
2.96
3.37
7.32
rham‘, T24. *Statistical significance between groups.
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time) and postabsorption factors (systemic distribution and
renal clearance) will apply equally to both. Therefore, the
L/R ratio is only influenced by the difference in gut perme-
ability for each molecule.21
Percentage recovery of single markers might be influ-
enced not only by the permeability of the intestinal mucosa
but also by preabsorption and postabsorption factors.
D-xylose and 3-O-methyl-D-glucose provide information
about the functional state of the intestinal mucosa, whereas
the L/R ratio is a reflection of the mucosal integrity at the
morphologic level.
Percentage recoveries for D-xylose and 3-O-methyl-D-
glucose did not differ substantially between the 2 groups.
There is a trend toward normality through the study period,
although at T24, percentage recoveries for both sugars are
far from values expected in healthy children.
Our study has shown that the use of dexamethasone
improved gut permeability at the morphologic level in our
patients. However, we have no explanation as to why dexa-
methasone did not affect the intestinal barrier at the func-
tional level. An L/R ratio of 0.46 is nearly 10 times the
normal value and is a reflection of a highly permeable
intestinal mucosa. Whether this implies that the patient is at
higher risk for intestinal bacterial translocation and subse-
quent sepsis or intestinal ischemia is not clear. The converse
is surely true. Patients given a diagnosis of necrotizing
enterocolitis have consistently high L/R ratios.22
A likely explanation for our results is the effect that
dexamethasone exerts in the postoperative production of
proinflammatory cytokines. The concentration of proin-
Figure 3. Changes of rhamnose percentage recovery in both
groups. Values are expressed as means (95% CI). , T0; , T12;
‘, T24. *Statistical significance between groups.
ET
Rflammatory cytokines decreases when steroids are used be-
The Journal of Thoracifore the commencement of CPB. This has been demon-
strated consistently in a number of studies.11,23 Several
cytokines, including interleukin 1 (IL-1), IL-4, IL-6, IL-10,
interferon , and tumor necrosis factor, have been reported
to increase intestinal permeability in vitro.3 IL-6, in partic-
ular, might be a mediator of intestinal mucosal injury in
various conditions associated with transient mesenteric hypo-
perfusion and subsequent inflammation.24
Figure 4. Changes of D-xylose percentage recovery in both
groups. Values are expressed as means (95% CI). , T0; , T12;
‘, T24. *Statistical significance between groups.
Figure 5. Changes of 3-O-methyl-D-glucose percentage recovery.
Values are expressed as means (95% CI). , T0;  T12; ‘, T24.
*Statistical significance between groups. 3OMG, 3-O-methyl-D-
CT
EDglucose.
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operation plus its addition to the pump prime appears to be
more beneficial.25 Administering steroids intravenously to
patients hours before the surgical procedure is, however,
often difficult for technical and logistical reasons. It has
been standard practice in our institution to use dexametha-
sone during induction of anesthesia only in patients under-
going a period of circulatory arrest. The results of the
present study are an encouragement to investigate whether
adding steroids to the pump prime might provide a better
improvement, faster improvement, or both in gut
permeability.
Nevertheless, the use of dexamethasone in pediatric car-
diac surgery remains a controversial issue. Lindberg and
colleagues26 stated that omitting the use of dexamethasone
in children weighing less than 10 kg scheduled for cardiac
surgery is unethical. Schroeder and associates25 accepted
that the lack of a control group without methylprednisolone
is a limiting factor in their study. It is, according to them,
standard practice to use steroids in these patients. However,
there are no prospective or retrospective cohort studies that
clearly show the influence of steroids on the clinical post-
operative course. In the present study, none of the patients
in the control group had gastrointestinal complications in
the postoperative period, and the clinical parameters mea-
sured were not affected by dexamethasone.
Use of dexamethasone to improve intestinal function is
not a new concept. As early as 1984, Bauer and coworkers27
noticed a reduction in the incidence of necrotizing entero-
colitis after prenatal glucocorticoid therapy. Animal models
have shown repeatedly that in the immature animal dexa-
methasone reduces bacterial translocation in the gut and
increases the length of the small intestine.28 The use of
dexamethasone (0.5 to 1 mg · kg1 · d1 for several days)
to treat or prevent chronic lung disease in preterm infants is
discouraged after intensive review of the literature.29 Our
patients were not premature, they were exposed to enteral
feeding, and their intestinal walls were far from immature.
The mechanisms by which dexamethasone exerts its
effects in the intestinal mucosa are not totally elucidated.
Further research might be necessary.
We thank our hospital pharmacy for the preparation and supply
of the sugar solution.
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